SEND: A New Tool for Delivering Cas9 and Other Therapeutically Important mRNAs
Time: 8:30 am
day: Day One
Details:
- SEND (Selective Endogenous Encapsidation for Cellular Delivery), offers a solution to the major technological delivery challenge with CRISPR
- An introduction to SEND and perspectives on how SEND system research can be advanced using genetically engineered mouse models
- resenting proof of principle experiments demonstrating SEND in vivo
